The impact of anti-mould prophylaxis on<i>Aspergillus</i>PCR blood testing for the diagnosis of invasive aspergillosis
Mario Cruciani, Werner Heinz(Universitätsklinikum Würzburg), P. Lewis White(University Hospital of Wales), B Jones(The University of Texas at San Antonio), Carlo Mengoli(University of Padua), Deborah Lockhart(University of Dundee), Oliver Morton(Western Sydney University), Catherine Cordonnier(Université Paris-Est Créteil), Lena Klingspor(Karolinska University Hospital), Adilia Warris(University of Exeter), Jessica Löffler(Universität Ulm), Barbora Weinbergerová(University Hospital Brno), Thomas R. Rogers(Scripps Research Institute), J. Peter Donnelly(Baylor College of Medicine), Johan Maertens(Unknown), Dieter Buchheidt, Rosemary A. Barnes(Innsbruck Medical University), Brian Jones(University of Glasgow)
Cited by 31
Related Papers
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
|Clinical Infectious Diseases|2008|4.9k
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
|Clinical Infectious Diseases|2019|2.8k
Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus
|Clinical Infectious Diseases|2002|2.3k
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
|New England Journal of Medicine|2007|1.8k
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline
|Clinical Microbiology and Infection|2018|1.5k